
    
      Combined RadioChemotherapy:

      Therapy start: within 28 days after bioptical diagnosis

      Radiotherapy: 5 x 5 days 1.8 Gy radiotherapy; cummulative dose 45 Gy

      Chemotherapy: Capecitabin 825mg/mÂ² bid, on each radiation day during the first 4 weeks RCTx

      Molecular Targeted Therapy: Bevacizumab 5 mg/kg body weight; day 1, 15, 29 Operation due to
      TME adherence to a break of min. 42 to max. 56 days after the last application of bevacizumab
    
  